MedTrace Logo

Can Dexmedetomidine For Procedural Sedation In Knee Arthroplasty Reduce Postoperative Pain? A Randomized Control Study

NCT02026141 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-06-20

Study results available
· View outcomes & findings →

Summary

Dexmedetomidine has been often used for procedural sedation. It has also has been shown to have a pain sparing effect. Therefore the investigators propose that if Dexmedetomidine is used for sedation in total knee replacements done under spinal anesthetic, the patients will have less pain up to 24 hours after the procedure.

Conditions

  • Total Knee Arthroplasty

Interventions

DRUG

Dexmedetomidine

DRUG

Normal Saline Placebo

Sponsors & Collaborators

  • University of Saskatchewan

    lead OTHER

Principal Investigators

  • Ian A Chan, MD · Department of Anesthesia, University of Saskatchewan, Canada

  • Jurgen Maslany, MD, FRCPC · University of Saskatchewan

  • Kyle Gorman, MD, FRCPC · University of Saskatchewan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02026141 on ClinicalTrials.gov